Validation of diagnostic utility of fasting plasma glucose and HbA1c in stable renal transplant recipients one year after transplantation

BACKGROUND: The use of HbA1c ≥6.5% for diagnosis of diabetes has been challenged for post-transplantation diabetes mellitus (PTDM) also known as new onset diabetes after transplantation (NODAT) due to a low sensitivity early after renal transplantation. PTDM diagnosed with an oral glucose tolerance...

Descripción completa

Detalles Bibliográficos
Autores principales: Ussif, Amin M., Åsberg, Anders, Halden, Thea Anine Strøm, Nordheim, Espen, Hartmann, Anders, Jenssen, Trond
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327477/
https://www.ncbi.nlm.nih.gov/pubmed/30630438
http://dx.doi.org/10.1186/s12882-018-1171-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6327477/
https://www.ncbi.nlm.nih.gov/pubmed/30630438
http://dx.doi.org/10.1186/s12882-018-1171-3

Ejemplares similares